Study to evaluate clinical performance of CyPath® Lung for the early detection of lung cancer in high-risk patientsMurtha Cancer Center Research Program at Uniformed Services University of the Health ...
Record CyPath® Lung Revenue and Unit Sales. Revenue from our noninvasive diagnostic for lung cancer increased 87% over 2024 with the number of tests performed rising 99% year over year, reflecting ...
InvestorsHub on MSN
BioAffinity launches large-scale clinical study for lung cancer detection technology
Affinity Technologies (NASDAQ:BIAF) announced on March 10, 2026, the launch of a large longitudinal clinical study involving 2,000 patients to evaluate the performance of its CyPath® Lung technology ...
Acute Myeloid Leukemia is the most common acute leukemia in adults affecting 2-6 adults per 100,000k globally.​ -With relapse rates as high as 50%, routine measurable residual disease (MRD) ...
The MarketWatch News Department was not involved in the creation of this content. Laboratory business streamlined in 2025 to focus on profitable diagnostic testing services including the Company's ...
Researchers identify five specific neuron subgroups in the motor cortex most vulnerable to TDP-43 protein clumps in ALS and Frontotemporal Dementia.
Bioimaging Core Facility The Bioimaging Core Facility is specialized in light microscopy. ChemBioMS - Mass Spectrometry Core Facility The ChemBiosMS - Mass Spectrometry Core Facility is a platform ...
The next question researchers want to answer is whether urine-derived lymphocytes can actually help inform responses to ...
Biomarker Testing Market Projected To Reach USD 50.76 Billion By 2035, Driven By Personalized Medicine And Oncology Advancements SNS Insider. The global market, valued at USD 32.69 billion in 2025, is ...
As non-animal models move mainstream, the focus is shifting toward reproducibility and data integrity. By using specialized ...
ACCESS GENEVA is an expertise center specialized in Automated confocal microscopy, High-content screening (HCS), High-throughput screening (HTS) and Flow cytometry cell sorting (FACS). We provide ...
The company's BV Flex test measures patient immune proteins in capillary blood samples to determine whether an individual has a bacterial or viral infection.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results